MedPath

MOXIFLOXACIN

MOXIFLOXACIN

Approved
Approval ID

723771a2-3e9a-e6f3-e053-2a91aa0a4d21

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 30, 2018

Manufacturers
FDA

DIRECT RX

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MOXIFLOXACIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-553
Application NumberANDA090080
Product Classification
M
Marketing Category
C73584
G
Generic Name
MOXIFLOXACIN
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJuly 30, 2018
FDA Product Classification

INGREDIENTS (6)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
BORIC ACIDInactive
Code: R57ZHV85D4
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 5 mg in 1 mL
Code: B8956S8609
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFLOXACIN - FDA Drug Approval Details